The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

It is estimated that around 30% of the population living in Western countries has metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of pathology (not attributed to alcohol/substance intake) initiated by steatosis and progression toward inflammation and irreversible fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Backer, Sean, Khanna, Deepesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576539/
https://www.ncbi.nlm.nih.gov/pubmed/37842470
http://dx.doi.org/10.7759/cureus.45231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576539/
https://www.ncbi.nlm.nih.gov/pubmed/37842470
http://dx.doi.org/10.7759/cureus.45231

Ejemplares similares